Send to

Choose Destination
Am J Gastroenterol. 2007 Dec;102(12):2789-92.

The changing face of Clostridium difficile: what treatment options remain?

Erratum in

  • Am J Gastroenterol. 2008 Feb;103(2):502. Dosage error in article text.


In this issue of the Journal, an article by Pepin et al. documents the shifting sands of the modern-day Clostridium difficile epidemic as seen in Quebec. Pepin and coauthors' observation that the superior activity of vancomycin over metronidazole has been lost since the emergence there of the hypervirulent strain NAP1/027 in 2003 has implications for the future treatment of C. difficile-associated diarrhea (CDAD). This editorial explores these, particularly in complicated cases and high-risk populations.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center